Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Tuesday

Treace Medical Concepts (NASDAQ:TMCI) is set to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.30) per share for the quarter. Treace Medical Concepts has set its FY 2024 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link.

Treace Medical Concepts (NASDAQ:TMCI) last issued its earnings results on Tuesday, February 27th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.01). Treace Medical Concepts had a negative net margin of 26.47% and a negative return on equity of 33.96%. The firm had revenue of $62.20 million during the quarter, compared to analyst estimates of $60.56 million. During the same period last year, the business earned ($0.08) EPS. The firm’s revenue was up 24.9% compared to the same quarter last year. On average, analysts expect Treace Medical Concepts to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Treace Medical Concepts Trading Up 2.7 %

NASDAQ TMCI opened at $11.00 on Monday. Treace Medical Concepts has a 52 week low of $5.27 and a 52 week high of $27.70. The firm has a 50 day moving average of $12.13 and a two-hundred day moving average of $11.71. The company has a quick ratio of 3.76, a current ratio of 4.40 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $679.36 million, a PE ratio of -13.58 and a beta of 0.37.

Treace Medical Concepts Company Profile

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.